INTELENCE 200 MG TABLET

etravirine
$24.2861per EA
High Outlier

Strength

200 mg/1

NDC

59676057101

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ETRAVIRINE

Approval Type

New Drug (NDA)

FDA Application

NDA022187

On Market Since

12/22/2010

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.2%

3Y

+1.8%

5Y

+6.3%

All

+73.3%